NALOXONE (“Narcan”) IS INSUFFICIENT TREATMENT FOR OPIOID USE DISORDER
To follow up on the letter of Abigail Tapper, MPH, that appeared in the July/August issue of Hadassah Magazine, she correctly recommends the availability of injectable naloxone (“Narcan”) to those who have regular contact with opioid users who are at risk for fatal opiate overdose. Naloxone saves lives because it immediately reverses the potentially fatal respiratory depression that opioid overdose causes. This is, of course, most laudable. Tapper does not mention, however, t